MITA released the results from it elections today and our CEO US has been elected for a three year term starting as the Vice Chair of the PET group. We wish Peter well and support Peter and the Molecular Imaging industry efforts to help promote growth and innovation in the Molecular Imaging Industry.
“I have participated on several committees and initiatives within the MITA PET Group since its foundation. My experience has been that this is a “can do” group of Molecular Imaging and Radiopharma professionals who work together to solve issues common to all stakeholders. We work on addressing patient advocacy/access issues, education, regulatory, coding and payment issues that affect our industry, customers, and patients. The key thing that we all focus on is that ultimately, we are here for the patients that need the products we produce to help diagnose and treat their diseases.
I am honored to have been chosen by my colleagues to serve as Vice Chair of the PET Group and join the MITA Leadership Committee. I will work with my MITA colleagues as well as other stakeholder organizations to serve our community.”